Abstract: Provided herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. Also provided are compositions including a compound of Formula (I) together with a pharmaceutically acceptable carrier, and methods for imaging prostate cancer cells.

Abstract: A power electronic module comprising a housing that receives at least one power converter is provided. The housing contains a polymer composition that includes an electromagnetic interference filler distributed within a polymer matrix. The polymer matrix contains a thermoplastic polymer having a deflection temperature under load of about 40° C. or more as determined in accordance with ISO 75-2:2013 at a load of 1.8 MPa. Further, the composition exhibits an electromagnetic interference shielding effectiveness of about 25 decibels or more as determined in accordance with ASTM D4935-18 at a frequency of 30 MHz and thickness of 3 millimeters.

Abstract: Provided herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. Also provided are compositions including a compound of Formula (I) together with a pharmaceutically acceptable carrier, and methods for imaging prostate cancer cells.

Abstract: Provided herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof, wherein L1 and L2 are each independently a covalent bond or a divalent linking group, R is a detectable label or therapeutic drug and B is an albumin binding moiety. Also provided are compositions including a compound of Formula (I) together with a pharmaceutically acceptable carrier, and methods for imaging prostate cancer cells using a compound of Formula (I).

Abstract: Provided herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof, wherein L1 and L2 are each independently a covalent bond or a divalent linking group, R is a detectable label or therapeutic drug and B is an albumin binding moiety. Also provided are compositions including a compound of Formula (I) together with a pharmaceutically acceptable carrier, and methods for imaging prostate cancer cells using a compound of Formula (I).

Abstract: We identified 17 transcription factor genes that regulate lipid production and activity in an organism. We subsequently detailed characterization of one of them (psr1). Constructs, methods and systems for enhancing or increasing lipid production in an organism are described.

Abstract: Provided herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. Also provided are compositions including a compound of Formula (I) together with a pharmaceutically acceptable carrier, and methods for imaging prostate cancer cells.

Abstract: A novel acid labile linker for targeted delivery and/or controlled release of agents is introduced herein. There is further disclosed a method of developing a therapeutic or diagnostic conjugate for targeted cell-specific delivery. More specifically, the invention is focused on linkers used to deliver anticancer agents to specific tumor cells.

Abstract: We identified 17 transcription factor genes that regulate lipid production and activity in an organism. We subsequently detailed characterization of one of them (psr1). Constructs, methods and systems for enhancing or increasing lipid production in an organism are described.

Abstract: We identified 17 transcription factor genes that regulate lipid production and activity in an organism. We subsequently detailed characterization of one of them (psr1). Constructs, methods and systems for enhancing or increasing lipid production in an organism are described.

Abstract: A novel acid labile linker for targeted delivery and/or controlled phosphoryl hydroxypropylglycine release of agents is introduced herein. There is further disclosed a method of developing a therapeutic or diagnostic conjugate for targeted cell-specific delivery. More specifically, the invention is focused on linkers used to deliver anticancer agents to specific tumor cells.

Abstract: We identified 17 transcription factor genes that regulate lipid production and activity in an organism. We subsequently detailed characterization of one of them (psr1). Constructs, methods and systems for enhancing or increasing lipid production in an organism are described.

Abstract: A modular and scalable power source can be used to supplement an existing source of power. In one embodiment, a DC source can be used to maintain a power source of a host system in a specific state in order to cause a desired behavior.

Abstract: A high rate discharge battery cell 150 is disclosed. The battery cell 150 comprising an anode end 200 and a cathode end 100 contains: a laminate including at least one anode electrode sheet 102; at least one cathode electrode sheet 101; and at least one separator sheet disposed between the anode electrode sheet 102 and the cathode electrode sheet 101; wherein the anode electrode sheet 102 projects outwardly of the edge of the laminate towards the anode end 200 of the battery cell 300; the cathode electrode sheet 101 projects outwardly of the edge of the laminate towards the cathode end 100 of the battery cell 150; a first current collector 203 in electrical contact with the outwardly projecting part of the anode electrode sheet 102 in the laminate formed by metal spray; and a second current collector 103 in electrical contact with the outwardly projecting part of the cathode electrode sheet 101 in the laminate formed by metal spray.

Abstract: A modular and scalable power source can be used to supplement an existing source of power. In one embodiment, a DC source can be used to maintain a power source of a host system in a specific state in order to cause a desired behavior.